(Q27635427)

1

0 references

R A Poorman

2

0 references

L C Kelley

3

0 references

K D Watenpaugh

4

0 references

C A Bannow

5

0 references

K L Leach

Journal of Biological Chemistry

6

0 references

language of work or name

English

0 references

publication date

21 December 2001

0 references

published in

0 references

volume

276

0 references

page(s)

48292-9

0 references

issue

51

0 references

cites work

The development and therapeutic potential of protein kinase inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Neuronal Cdc2-like kinases: neuron-specific forms of Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Cyclin-dependent kinases: engines, clocks, and microprocessors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Cyclins and cell cycle checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Cell cycle molecular targets in novel anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

CDK inhibition and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Neuronal Cdc2-like kinase: from cell cycle to neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Role of cyclins in neuronal differentiation of immortalized hippocampal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Neurotoxicity induces cleavage of p35 to p25 by calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Preclinical and clinical development of cyclin-dependent kinase modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

p38-2, a novel mitogen-activated protein kinase with distinct properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Purification and crystallization of human cyclin-dependent kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

PROCHECK: a program to check the stereochemical quality of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

A pharmacokinetic analysis program (multi) for microcomputer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Use of an oriented peptide library to determine the optimal substrates of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

18 Use of competitive inhibitors to study substrate binding order

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Crystal structure of cyclin-dependent kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Identification of functional domains in the neuronal Cdk5 activator protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200

Raster3D: photorealistic molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102034200